1. PI3K/Akt/mTOR
    Metabolic Enzyme/Protease
  2. PTEN
  3. SF1670


Cat. No.: HY-15842 Purity: >98.0%
Handling Instructions

SF1670 is a potent and specific phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor.

For research use only. We do not sell to patients.

SF1670 Chemical Structure

SF1670 Chemical Structure

CAS No. : 345630-40-2

Size Price Stock Quantity
10 mM * 1  mL in DMSO USD 132 In-stock
Estimated Time of Arrival: December 31
5 mg USD 120 In-stock
Estimated Time of Arrival: December 31
10 mg USD 156 In-stock
Estimated Time of Arrival: December 31
25 mg USD 348 In-stock
Estimated Time of Arrival: December 31
50 mg USD 636 In-stock
Estimated Time of Arrival: December 31
100 mg USD 1056 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 9 publication(s) in Google Scholar

Top Publications Citing Use of Products

    SF1670 purchased from MCE. Usage Cited in: Mol Med Rep. 2018 Jul;18(1):349-357.

    The Western blotting data indicates that the enhanced expression of PTEN and FAK is decreased by SF1670. And the decreased expression of p-PI3K/p-Akt is augmented by SF1670.
    • Biological Activity

    • Protocol

    • Purity & Documentation

    • References

    • Customer Review


    SF1670 is a potent and specific phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibitor.

    IC50 & Target


    In Vitro

    SF1670 is a specific PTEN inhibitor with prolonged intracellular retention in neutrophils. SF1670 enhances PtdIns(3,4,5)P3 signaling in transplanted neutrophils. SF1670 also elevates Akt phosphorylation in murine cells. Consistent with the enhanced Akt phosphorylation, pretreatment with SF1670 also significantly augments PtdIns(3,4,5)P3 level in mouse neutrophils. SF1670-induced Akt hyperactivation is abolished in PTEN-null neutrophils, further demonstrating that this effect is mediated by specific inhibition of PTEN activity. At 500 nM fMLP stimulation, SF1670 (500 nM)–pretreated neutrophils show nearly 70% higher (maximal) superoxide production than untreated neutrophils[1]. HCT116 cells are pre-treated with the PTEN inhibitor SF1670 (2 μM) for 24 h (untreated HCT116 cells served as control); treated cells are subsequently plated under non-adherent conditions with added MET (60 μM), Lun (2 μM), or Gen (2 μM). SF1670 binds to the PTEN active site, resulting in elevated phosphatidylinositol (3,4,5) triphosphate signaling[2].

    Molecular Weight




    CAS No.





    Room temperature in continental US; may vary elsewhere.

    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 50 mg/mL (162.69 mM)

    H2O : < 0.1 mg/mL (insoluble)

    *"≥" means soluble, but saturation unknown.

    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.2537 mL 16.2686 mL 32.5373 mL
    5 mM 0.6507 mL 3.2537 mL 6.5075 mL
    10 mM 0.3254 mL 1.6269 mL 3.2537 mL
    *Please refer to the solubility information to select the appropriate solvent.
    In Vivo:
    • 1.

      Add each solvent one by one:  10% DMSO    90% corn oil

      Solubility: ≥ 2.5 mg/mL (8.13 mM); Clear solution

    *All of the co-solvents are provided by MCE.
    Cell Assay

    The human colon cancer cell lines HT29 and HCT116 are propagated in McCoy’s medium (ATCC) supplemented with 10 % fetal bovine serum (FBS) and 5 % antibiotic-antimycotic solution (ABAM) in a humidified incubator (5 % CO2:95 % air) at 37°C. Cells are seeded in six-well plates at an initial density of 2×105 per well, and treated (in culture medium) with Metformin (MET 60 μM), Lunasin (Lun 2 μM), β-conglycinin (β-con 3 μM), Glycinin (Gly 3 μM), and Genistein (Gen 2 μM), alone or in combination. β-con and Gly are isolated and purified as described below. Metformin, Lun, β-con, and Gly are dissolved in phosphate-buffered saline (PBS), whereas Gen is dissolved in DMSO. In other experiments, cells are treated with insulin (2 μM), PTEN inhibitor SF1670 (2 μM), and 5-Fluorouracil (5-FU 50 μM). Treated cells are collected at select time points for subsequent analyses[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2


    SF1670SF 1670SF-1670PTENPhosphataseAutophagyPhosphatase and tensin homologMMAC1Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name



    Applicant Name *


    Email address *

    Phone number *


    Organization name *

    Department *


    Requested quantity *

    Country or Region *



    Bulk Inquiry

    Inquiry Information

    Product Name:
    Cat. No.:
    MCE Japan Authorized Agent: